CLINICAL TRIAL HIGHLIGHTS: 1. GENE THERAPY FOR PARKINSON’S, 2. PHASE 3 STUDY IN FOCUS - INTEC PHARMA’S ACCORDION PILL, 3. CLINICAL TRIALS RESOURCES

Detalles Bibliográficos
Autores principales: McFarthing, Kevin, Prakash, Neha, Simuni, Tanya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2019
Materias:
Clinical Trial Highlights
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598021/
https://www.ncbi.nlm.nih.gov/pubmed/31127735
http://dx.doi.org/10.3233/JPD-199001
_version_ 1783430687540379648
author McFarthing, Kevin
Prakash, Neha
Simuni, Tanya
author_facet McFarthing, Kevin
Prakash, Neha
Simuni, Tanya
author_sort McFarthing, Kevin
collection PubMed
description
format Online
Article
Text
id pubmed-6598021
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher IOS Press
record_format MEDLINE/PubMed
spelling pubmed-65980212019-07-01 CLINICAL TRIAL HIGHLIGHTS: 1. GENE THERAPY FOR PARKINSON’S, 2. PHASE 3 STUDY IN FOCUS - INTEC PHARMA’S ACCORDION PILL, 3. CLINICAL TRIALS RESOURCES McFarthing, Kevin Prakash, Neha Simuni, Tanya J Parkinsons Dis Clinical Trial Highlights IOS Press 2019-05-23 /pmc/articles/PMC6598021/ /pubmed/31127735 http://dx.doi.org/10.3233/JPD-199001 Text en © 2019 – IOS Press and the authors. All rights reserved https://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) License (https://creativecommons.org/licenses/by-nc/4.0/) , which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Trial Highlights
McFarthing, Kevin
Prakash, Neha
Simuni, Tanya
CLINICAL TRIAL HIGHLIGHTS: 1. GENE THERAPY FOR PARKINSON’S, 2. PHASE 3 STUDY IN FOCUS - INTEC PHARMA’S ACCORDION PILL, 3. CLINICAL TRIALS RESOURCES
title CLINICAL TRIAL HIGHLIGHTS: 1. GENE THERAPY FOR PARKINSON’S, 2. PHASE 3 STUDY IN FOCUS - INTEC PHARMA’S ACCORDION PILL, 3. CLINICAL TRIALS RESOURCES
title_full CLINICAL TRIAL HIGHLIGHTS: 1. GENE THERAPY FOR PARKINSON’S, 2. PHASE 3 STUDY IN FOCUS - INTEC PHARMA’S ACCORDION PILL, 3. CLINICAL TRIALS RESOURCES
title_fullStr CLINICAL TRIAL HIGHLIGHTS: 1. GENE THERAPY FOR PARKINSON’S, 2. PHASE 3 STUDY IN FOCUS - INTEC PHARMA’S ACCORDION PILL, 3. CLINICAL TRIALS RESOURCES
title_full_unstemmed CLINICAL TRIAL HIGHLIGHTS: 1. GENE THERAPY FOR PARKINSON’S, 2. PHASE 3 STUDY IN FOCUS - INTEC PHARMA’S ACCORDION PILL, 3. CLINICAL TRIALS RESOURCES
title_short CLINICAL TRIAL HIGHLIGHTS: 1. GENE THERAPY FOR PARKINSON’S, 2. PHASE 3 STUDY IN FOCUS - INTEC PHARMA’S ACCORDION PILL, 3. CLINICAL TRIALS RESOURCES
title_sort clinical trial highlights: 1. gene therapy for parkinson’s, 2. phase 3 study in focus - intec pharma’s accordion pill, 3. clinical trials resources
topic Clinical Trial Highlights
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598021/
https://www.ncbi.nlm.nih.gov/pubmed/31127735
http://dx.doi.org/10.3233/JPD-199001
work_keys_str_mv AT mcfarthingkevin clinicaltrialhighlights1genetherapyforparkinsons2phase3studyinfocusintecpharmasaccordionpill3clinicaltrialsresources
AT prakashneha clinicaltrialhighlights1genetherapyforparkinsons2phase3studyinfocusintecpharmasaccordionpill3clinicaltrialsresources
AT simunitanya clinicaltrialhighlights1genetherapyforparkinsons2phase3studyinfocusintecpharmasaccordionpill3clinicaltrialsresources

Ejemplares similares